Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face

NCT01720407 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

259

Enrollment

OTHER

Sponsor class

Conditions

Lentigo Maligna Melanoma (Head or Neck)

Interventions

DRUG: Imiquimod cream + surgery
DRUG: Placebo + surgery

Sponsor

Nantes University Hospital

Collaborators

[object Object]